Mohammed K. Abd El‐Gaber

This researcher works in medicinal and organic chemistry, focusing on designing and synthesizing new drug-like molecules, including fluorine-containing compounds and derivatives of known antibiotics and anticancer agents. Much of the work combines chemical synthesis with computational modeling and laboratory testing to evaluate potential drugs against cancer cells and bacteria. The research also includes methodological work on introducing fluorine atoms into organic molecules, a common strategy in drug design.

Publication output was minimal or absent from 2018–2021 but has increased noticeably since 2022, with the most active years being 2023 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026